Western Michigan University

ScholarWorks at WMU
Master's Theses

Graduate College

8-1978

An in Vitro Study of the Effects of 17Β
17 Estradiol on a Possible
Atherosclerotic-Causing Enzyme, Xanthine Oxidase
Peter E. Malo

Follow this and additional works at: https://scholarworks.wmich.edu/masters_theses
Part of the Anatomy Commons, and the Veterinary Physiology Commons

Recommended Citation
Malo, Peter E., "An in Vitro Study of the Effects of 17Β Estradiol on a Possible Atherosclerotic-Causing
Enzyme, Xanthine Oxidase" (1978). Master's Theses. 2143.
https://scholarworks.wmich.edu/masters_theses/2143

This Masters Thesis-Open Access is brought to you for
free and open access by the Graduate College at
ScholarWorks at WMU. It has been accepted for inclusion
in Master's Theses by an authorized administrator of
ScholarWorks at WMU. For more information, please
contact wmu-scholarworks@wmich.edu.

AN IN VITRO STUDY OF THE EFFECTS OF 1?B ESTRADIOL ON A
POSSIBLE ATHEROSCLEROTIC-CAUSING ENZYME, XANTHINE OXIDASE

Peter E. Malo

A Thesis
Submitted to the
Faculty of The Graduate College
in partial fulfillment
of the
Degree of Master of Arts

Western Michigan University
Kalamazoo, Michigan
August 1978

R eproduced with permission of the copyright owner. Further reproduction prohibited without permission.

ACKNOWLEDGEMENTS

In researching and writing this thesis I have be
come indebted to many people.
naming but a few,

Space prevents me from

I thank Mrs. Phoebe Rutherford who gave

me my assistantship when it was so badly needed,

I thank

Dr. Charles Day of The Upjohn Company, Kalamazoo, Michigan
for his excellent help in the technical aspects of this
project.

I am also grateful to Dr. Elizabeth Reisender

of Michigan State University for her help as a good friend
and colleague in the face of problem after problem.
Finally, I owe my gratitude and sincere thanks to
Drs. Gian C. Sud and Richard W. Pippen without whose help
and guidance this thesis would not have been possible,
and for this I wish to thank them publicly,
Peter E. Malo

R eproduced with permission of the copyright owner. Further reproduction prohibited without permission.

INFORMATION TO USERS

This material was produced from a microfilm copy of the original document. While
the most advanced technological means to photograph and reproduce this document
have been used, the quality is heavily dependent upon the quality of the original
submitted.
The following explanation of techniques is provided to help you understand
markings or patterns which may appear on this reproduction.
1 .T h e sign or "target" for pages apparently lacking from the document
photographed is "Missing Page(s)". If it was possible to obtain the missing
page(s) or section, they are spliced into the film along with adjacent pages.
This may have necessitated cutting thru an image and duplicating adjacent
pages to insure you complete continuity.
2. When an image on the film is obliterated with a large round black mark, it
is an indication that the photographer suspected that the copy may have
moved during exposure and thus cause a blurred image. You will find a
good image of the page in the adjacent frame.
3. When a map, drawing or chart, etc., was part of the material being
photographed

the

photographer

followed

a

definite

method

in

"sectioning" the material. It is customary to begin photoing at the upper
left hand corner of a large sheet and to continue photoing from left to
right in equal sections w ith a small overlap. If necessary, sectioning is
continued again — beginning below the first row and continuing on until
complete.
4. The majority of users indicate that the textual content is of greatest value,
however, a somewhat higher quality reproduction could be made from
"photographs" if essential to the understanding o f the dissertation. Silver
prints of "photographs" may be ordered at additional charge by writing
the Order Department, giving the catalog number, title, author and
specific pages you wish reproduced.
5. PLEASE

NOTE:

Some pages may have indistinct print. Filmed as

received.

U niversity M ic ro film s In tern a tio n a l
300 North Zeeb Road
Ann Arbor, M ichigan 48106 USA
St. John's Road, Tyler's Green
H igh W ycombe, Bucks, England HP10 8HR

R eproduced with permission of the copyright owner. Further reproduction prohibited without permission.

131213b
malo,

peter e ,
AN I N VITRO STUDY OF THE EFFECTS UF 17 BETA
ESTRADIOL Oi-i A POSSI BLE
a t h e r o s c l e r o t i c - c a u s i n g ENZuMEf x a n t h i n e
OXI DASE.

WESTERN MICHIGAN UNI VERSI TY*

University
Microfilms
International

300

n

M. A , »

1970

z e e b r o a d , a n n a r b o r ,m i a s k k

R eproduced with permission o f the copyright owner. Further reproduction prohibited without permission.

TABLE OF CONTENTS

CHAPTER
I

PAGE
THE PROBLEM OF ATHEROSCLEROSIS ...........

1

....

1

Introduction
II
III

LITERATURE SURVEY .... ................... 6
MATERIALS AND METHODS

.........

Isolation of the Low Density
Lipoprotein
....

13
13

Trace Labeling of the Lipoprotein ....... 15
Organ Culture of Aortic Tissue .......... 1?

IV
V
VI

Preparation of the Xanthine Oxidase
.....
Solution

19

Addition of Isotopic Lipoprotein and
17B Estradiol to the Cultures .........

21

RESULTS

.....

DISCUSSION OF FINDINGS . .............
CONCLUSIONS ............

2k

30
. 39

R eproduced with permission of the copyright owner. Further reproduction prohibited without permission.

THE PROBLEM OF ATHEROSCLEROSIS

Introduction
Each year in the United States more than fifty per
cent of all deaths are due to cardiovascular disease,
eighty-four percent of which is due to one type of dis
ease known as atherosclerosis (Chemical and Engineering
News, 1975)*

Indeed, a published report by a task force

of the National Heart and Lung Institute indicates that
atherosclerosis is the chief cause of death in the United
States (NIH, 19?1).
Atherosclerosis is a general term which covers the
following pathologies! intimal proliferation of smooth
muscle cells and accumulation of large amounts of connec
tive tissue matrix (including collagen, elastic fibers,
and depostion of intracellular and extracellular lipids)
(Wissler, Vesselinovitch, 1969)•

Symptoms of atherosclero

sis are caused by the narrowing of an artery which causes
an inadequacy of blood supply to the affected area; this
results in cell death and necrosis of the area of tissue
supplied by the narrowed artery,
Anitschkow and Chalatov, in 1909, first emphasized
the probable role of dietary cholesterol in atherogenesis, and shortly thereafter began studying the effects of
excessive cholesterol feeding in rabbits.

They believed

that the high level of cholesterol in the plasma is the

1
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inciting cause of atherosclerosis, and maintained that the
causation of the disease may he traced to a general dis
order of the lipid metabolism.

This disorder may be ei

ther the result of excessive consumption of lipids or im
paired control of lipid metabolism by the endocrine organs.
Some research contends that cholesterol is one of
the major factors in the occurrence of atherosclerosis.
It is still not known just how high the levels of certain
plasma lipids must be to initiate the lesions on the art
ery, but it has become generally accepted that once the
large molecular complexes of beta and pre-beta lipoproteins,
which carry the cholesterol molecule to the cells are in
the intimal layers of the artery, a chain of events com
mence which culminate in the appearence of the lesion (Haust,
More, 1972).

Smooth muscle cell proliferation is believed

to be the initial cellular event in the pathogenesis of
atherosclerosis (Ross, Glomset, 1976).

A stimulus, such

as an injury, a chemical or a virus, is thought to cause
smooth muscle cells to migrate into the intima, where they
may transform, proliferate, produce connective tissue and
lipid and thus initiate the early lesion.
The stimulus of current belief is that of cholesterol,
because it is usually a major component of atherosclerotic
lesions.

Most investigations are concerned with the route

by which cholesterol gets into the lesions.

Recently,

attention has focused on a special class of plasma lipids

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

3

called lipoproteins.
a protein carrier.

They are composed of a lipid part and
The beta lipoprotein, or known also as

a low density lipoprotein, serves as a carrier for cholesterol,
binding the cholesterol to itself and then carrying it thru
the circulatory system to whatever cells need it.
Low density lipoproteins and another class of lipo
proteins called high density lipoproteins appear to have
opposing effects in atherosclerosis.

A high level of low

density lipoprotein, as in patients with Type Ila hyper
lipoproteinemia, strongly correlates with early athero
sclerosis (Fredrickson, Levy, 1972).

A high level of high

density lipoprotein appears to be protective (Miller, Miller,
1975)'

Studies in animals (Sinderman, et. al., 197^) and

tissue cultured cells (Brown, Goldstein, 1976) have sug
gested that low density lipoprotein supplies cholesterol to
tissues and high density lipoprotein removes it.
Recent work with cultured fibroblasts and other
cultured cells has led to the hypothesis that cholesterol
synthesis and uptake of low density lipoprotein are related
to cellular levels of cholesterol (Fogelman, et. al., 1977).
There is evidence that certain cell surface receptors exist
for low density lipoproteins (Brown, Goldstein, 197^)*
Binding of the lipoprotein with the receptor must occur
before the degradation of the low density lipoprotein and
the suppression of cholesterol synthesis can occur in the
cells.

Receptors for low density lipoprotein are nearly
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if

absent, and synthesis of new cholesterol is inhibited when
cellular cholesterol level is high.

When extracellular

cholesterol is low, meaning there is a corresponding low
level of low density lipoprotein, cellular cholesterol
falls.

The cell then accelerates intracellular synthesis

of new cholesterol from acetate and, later, increases
low density lipoprotein receptor concentrations on the cell
surface.
Patients v/ith familial homozygous hypercholestero
lemia lack a cell surface receptor for low density lipo
protein.

These patients do not take up the lipoprotein

at normal serum levels (Brown, Goldstein, 1976).

Only at

high serum levels of the low density lipoprotein will
enough cholesterol enter the cell and inhibit cellular
synthesis.

Because of this inborn error, there is an

extremely large pool of low density lipoprotein, but over
all cholesterol synthesis is normal or only slightly ele
vated, although it should have been depressed.

Hyper-

cholesteremic patients develop atherosclerosis at a very
early age.
The low density lipoprotein molecule, because of its
role as the cholesterol carrier, is currently being inves
tigated in several laboratories (Brown, Goldstein, 1976;
Eisenberg, Levy, 1975; Rothblat, Kritchevsky, 1968; Oster,
1971) as a possible etiological agent in the formation
of atheromatous plaques in human arteries.
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The purpose of this thesis was to study the effects
of the atherosclerosis-causing enzyme found in bovine milk.
The enzyme is called xanthine oxidase.

My work involved

a study of the effects of the enzyme on the low density
lipoprotein receptor and the inhibition of the enzyme by
the principle estrogen, 1?B estradiol.

The results may

have far reaching significance on the treatment and pre
vention of atherosclerosis, for as yet no treatment can be
prescribed.
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L IT E R A T U R E

SURVEY

No species appears to be immune from the development
of atherosclerosis, if it is subjected to a sustained
elevation of its blood lipids.

This is also true if an

elevated condition of low density lipoprotein occurs
(Wissler, Vesselinovitch, 1969).
The human low density lipoprotein particle is 220
8 in diameter; it contains a core of cholesterol ester
and triglyceride and an outer shell of free cholesterol,
phospholipid and apoprotein B (Small, 1977)»

Cholesterol

composes roughly fifty percent of the low density lipo
protein mass, predominantly in the esterified form.

Protein

and phospholipids comprise about twenty to twenty-five per
cent each of the total mass,

Human plasma low density lipo

protein is formed largely, if not entirely, in the cir
culation.

Cholesterol is readily exchangeable among lipo

proteins and between lipoproteins and tissue, and is re
utilized for synthesis of new lipoproteins.

Low density

lipoprotein turnover studies suggest that circulating
low density lipoprotein levels are determined primarily by
their removal rate from the plasma rather than their pro
duction rate (Eisenburg, Levy, 1975)«
Many studies during the 1960’s have demonstrated
that lipids, when added to the growth media, have a pro
found effect on cholesterol metabolism of cells grown in

6
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tissue culture.

Two studies have followed the fate of rat

plasma low density lipoprotein and high density lipoprotein
labeled with iodine 125 in cultures of rat aortic smooth
muscle cells (Bierman, Stein, Stein, 197*0; the uptake of
radioactivity increased in proportion to the time of in
cubation and amount of lipoprotein in the growth media, and
a large proportion of either lipoprotein was apparently sur
face bound and trypsin releasable.
A number of workers (Rothblat, Kritchevsky, 1968, Burns,
Rothblat, 1969, Bates, Rothblat, 197*0 have all conclusively
shown that in cells derived from mouse fibroblasts (from the
L cell line), the rate of sterol synthesis is dependent on
the flux of cholesterol into the cell and from the cell.
They have also pointed toward several specific substances
affecting sterol metabolism in these cells, lipoproteins being
one of the major sterol synthesis suppressing factors.
To strengthen this hypothesis, a study with skin fibro
blasts from patients with T;ype Ila hyperlipoproteinemia
demonstrated an absence of cholesterol synthesis inhibition
by lipoproteins,

The cells did not bind low density lipo

protein to any appreciable degree (Brown, Goldstein, 197*0.
Their observations show the specific role of low density
lipoprotein as delivering cholesterol to cells through a
binding at a specific site, and that familial hyperbetalipoproteinemia resulted from defective low density lipoprotein
clearence.

R eproduced with permission o f the copyright owner. Further reproduction prohibited without permission.

Smooth muscle cells from human arteries take up large
quantities of low density lipoprotein with lesser amounts
of high density lipoprotein, while cultured smooth muscle
cells from rat arteries take up more high density lipo
protein than low density lipoprotein (Bierman, 1972).

How

ever, rats are very resistant to the development of athero
sclerosis, whereas humans readily develop the condition.
Some investigators have postulated that the etiology
of atherosclerosis lies not neccessarily in an overabun
dance of cholesterol, triglycerides or lipoproteins, but
rather in a deficiency of a defined molecule localized in
the inner tissue layer of the artery (Oster, Ross, Ptaezinski, 1973)-

The deficiency of molecules would secondarily

allow infiltration by cholesterol.

The cholesterol would

become esterified with unsaturated oleic acid (from the in
gestion of polyunsaturated fats) in the depleted area.

This

arterial cell membrane component is called plasmalogen.
Plasmalogen is a polar molecule composed of phospholipid
esters of either palmitic or steric aldehydes.

Up to thirty

percent of the phospholipids found in the heart muscle are
plasmalogen, but other metabolically active organs have cell
membranes which are devoid of plasmalogens, namely the liver
and mucous membranes of the small intestine.

The absence of

plasmalogen in the liver is due to the activity of the enzyme
xanthine oxidase, which is present in abundance in the liver
(Mulinos, Oster, 19^)•
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Plasmalogen is one of the many structural components
in the cell membrane, and may serve as a substrate for a re
action with xanthine oxidase, the aldehyde portion of the
plasmalogen molecule undergoing oxidation.

If the myo

cardium is depleted of plasmalogen with xanthine oxidase
and then given allopurinol, which is a known inhibitor of
xanthine oxidase, depleted plasmalogen will eventually be
restored, showing a dose-effect relationship between
plasmalogen and xanthine oxidase (Oster, 1971).
Ectopic xanthine oxidase could be a factor inducing
serious inflammation or perfusion of the arterial endo
thelium or myocardium (Oster, 1973).

source of the

enzyme may be the liver cell, since patients with acute
liver disease show increased serum levels of xanthine
oxidase (Shamma'a, 1965).

The only food source containing

a significant amount of this enzyme is bovine milk.

The

dairy industry pasteurizes at 170°F., with a fifteen
second holding period, and this process leaves about
forty-two percent of the xanthine oxidase still active.
In addition, the milk xanthine oxidase exists as part of a
microsomal particle, situated ir. the fat globules.

During

the process of homogenization, fat droplets are altered,
broken up and reduced in size from 3*5u to an average of
about l.Ou.

This increases the number of fat globules

some one hundred percent and expands the fat globule sur
face between six and seven times (Oster, 1971).
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This micronization increases the rate of absorption of xan
thine oxidase by the villi of the small intestine, facilitat
ing their entry into the bloodstream.

It has been shown by

specific hemagglutination of sensitized sheep red blood cells
that milk proteins were absorbed into the human bloodstream
(Davies, 1971)•

It is therefore possible that this ectopic

xanthine oxidase may encounter a suitable substrate in the
aldehyde moiety of the plasmalogen phospholipid.

The sub

sequent integrity of the cell membrane due to the oxidation
of the aldehyde portion by xanthine oxidase, may produce the
initial lesion which could then serve to increase cell per
meability, microthrombus deposition, or both.

Grossly nor

mal aortic tissues have been shown to have little or no de
tectable enzyme activity, however, sections of aorta con
taining visible atherosclerotic plaques showed significantly
higher levels of xanthine oxidase activity (Oster, Ptaezinski, Ross, 1973)*

In addition, opposing concentrations

of plasmalogen were found; that is normal arteries con
tained high concentrations of plasmalogen while those of
the atherosclerotic condition contained abnormally low
amounts.
Certain hormones present in the body can cause an
inhibition of the atherosclerotic disease process.

It

has been shown that xanthine oxidase activity is stimulated
by androgen and testosterone and inhibited by the estrogens,
the most potent being 17B estradiol (Roussos, 1963).

This
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inhibition by 1?B estradiol could account for the lower in
cidence of atherosclerosis seen in pre-menopausal females
and extremely high incidence of the disease in males and
post-menopausal females caused by the stimulation of the
xanthine oxidase by androsterone and testosterone.

Besides

acting on the enzyme, plasmalogen has been shown to be a
target substance for the action of male and female sex
hormones (Oster, 19^5).

The distribution of plasmalogen

in the female rat kidney was governed by the phases of the
esterous cycle? the disappearance and reappearance of
plasmalogens could be duplicated in the castrated male
animal by the administration of female hormones.

These

changes, should they occur also in the human organism,
might possibly explain the lower incidence of myocardial
infarction in women of child-bearing age then in men of
the same age group.
This study will be concerned with the proof of the
involvement of xanthine oxidase in the development of
atherosclerosis in cultured arteries and to show that
the low density lipoprotein receptor and the plasmalogen
molecule are linked to the enzyme^s detrimental effects.
My work will also show that this effect can be inhibited by
the female hormone 17B estradiol.

The experimental system

used involved aortic tissue and blood samples obtained from
freshly slaughtered hogs at a local slaughterhouse,

A

porcine source was used because they, of all the animal
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models available, are most similiar to humans in how they
develop atherosclerotic lesions (Scott, Daoud, Florentin,
1969).

Dorsal aorta was chosen because of its ease of

accessibility and the aorta is the one major artery common
ly affected (Ross, Glomset, 1973)*

It is important that an

in vitro model be chosen that will closely equal the human
arterial intima, therefore the porcine model was used becaus
it is very similiar histologically to the human arterial
intima.
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MATERIALS AND METHODS
Isolation of the
Low Density Lipoprotein
A partially purified low density lipoprotein sub
fraction may be obtained by precipitation from serum with
the addition of sodium phosphotungstate and magnesium chlo
ride.

There will be slight contamination by another lipo

protein subfraction, which is a very low density lipoprotein.
However, the concentration of the contaminant will have
little bearing on this experiment because of the amount pre
sent is so small (Burnstein, Scholnick, 1972).
Porcine blood was filtered through a double layer of
cheesecloth to remove clotted blood.

It was then placed into

a fifty milliliter centrifuge tube.

The tubes were then spun

for fifteen minutes at 1500-2000 r.p.m. in a Sorval non
refrigerated centrifuge.
serum was removed.

The supernatant containing the

Centrifugation may be repeated if a clear

separation was not achieved the first time.

For every two

hundred-fifty milliliters of serum, twenty-five milliliters
of a four percent sodium phosphotungstate solution and six
point two five milliliters of a two molar solution of mag
nesium chloride were added to selectively precipitate the
low density lipoprotein subfraction,

The mixture was immed

iately centrifuged at 6000 r.p.m. for ten minutes.

The

supernatant was decanted and the precipitates dissolved

13
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in 1,0 liters of nonbuffered 0,2 percent sodium citrate,
with the use of a magnetic stirring bar.

After the pre

cipitate was dissolved, 10,0 grams of sodium chloride were
added to the solution.

The low density lipoprotein was

reprecipitated after this washing stage by the addition of
thirty milliliters of 2.0M magnesium chloride solution.
The precipitate was recovered by centrifugation, and this
washing step was repeated once to eliminate protein im
purities .
The washed precipitate was dissolved into ten milli
liters of a ten percent sodium citrate solution, at 37°c
and by the addition of a few crystals of ammonium chloride
Solubilized lipoprotein solution was dialyzed against
1.0 liters of a three percent sodium citrate, ten percent
ammonium chloride solution to remove traces of sodium
phosphotungstate, for twenty-four hours, and then it was
dialyzed against a Tris-hydrochloric acid-sodium chloride
buffer, pH 7,7, for twenty-four hours to eliminate the
citrate and ammonium chloride (Burnstein, Scholnick, 19?2)
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The Labeling of the Lipoprotein
To a solution containing 2.0 milliliters of a
sodium phosphate buffer (pH 7.2, containing 0.9 percent
sodium chloride), and 3.0 milliliters of a carbonatebicarbonate buffer (10.6 gm. NagCO^, 2.8 gm. NaHCO^ in
fifty milliliters of warm distilled water, final pH 9.9)
was added 200 mg. of low density lipoprotein solution.
The 125-iodine (2.0mCi, specific activity 17.0 Ci/mg.
carrier-free ICN//63037, ICN Radioisotope Division, Irvine,
California) received 0.76 milliliters of water and then
0.^ milliliters of iodine monochloride solution.

A drop

of 1.0N HC1 was added to the solution to create an iodinehypoiodite-iodine 125 solution.
A 0 .3M aminoacetic acid buffer was prepared, as was
a 0.026M sodium tetraborate buffer,

To fifty milliliters

of the 0.026M sodium tetraborate buffer, 15*2 milliliters
of 0.1N HC1 was added, and after mixing, 100 milliliters
of the 0.3M aminoacetic acid was added to the solution.
The aminoacetic-sodium tetraborate buffer (final pH
of 8.5) was added to the iodine-hypoiodite-iodine 125
solution, which was then added dropwise to the low density
lipoprotein mixture for two hours at 37»5°C with stirring.
Under the above conditions, a given hydrogen atom on
the protein portion of the lipoprotein will be exchanged
for a non-radioactive iodine atom.

This is the substi
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tution portion of the reaction.

Once the iodine has be

come incorporated into the portion of protein, a simple
exchange reaction occurs between the nonradioactive iodine
and the iodine 125*

Therefore, at any given time some

portion of the lipoprotein will be tagged with the radio
active iodine 125»

Since the hypoiodite is unstable at a

pH of greater than 9*5» the pH of the solution was careful
ly monitored to be kept in the range of pH 8.5 to 9*0*
After the incubation period, 0,5 milliliters of a
one hundred percent trichloroacetic acid solution was added
to precipitate the lipoprotein.

The supernatant was with

drawn for counting in a Packard Tri-Carb 3310 Refrigerated
Liquid Scintillation Counter.

The lipoprotein solution

was adjusted to give a reading of 300,000 counts per min
ute by diluting the solution with a sodium phosphate buffer
after the labeled low density lipoprotein was dialyzed at
2-4°C against two liters of sodium phosphate buffer (pH
0,9 percent sodium chloride, 0,5 percent potassium iodide)
for twenty-four hours and then changed to a saline buffer
without the potassium iodide, but with 3*0^ EDTA for an
additional twelve hours.

After the final dialyzing bath,

the solution was sterilized by passage through a sterile
Millipore filter (pore size, 0.A5 microns)(Snyder, Piantadosi, 19661 McFarlane, 1958; Chase, Rabinowitz, 196?).
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Organ Culture of Aortic Tissue
Porcine dorsal aorta were obtained from a local
slaughterhouse and transported in cold physiological
saline on ice to the laboratory.
Under the asceptic conditions in a tissue culture hood,
the aorta were cut longitudinally into strips approxi
mately two centimeters wide.

The strips were cleaned of

any branching arteries along with fat and mesentery.
These strips were then placed into a solution of warm physi
ologic saline with an antibiotic solution.

The antibiotic

solution consisted of streptomycin sulfate, 100 units per
milliliter, penicillin G (potassium salt), 100 units per
milliliter, and a fungicide, Nystatin, 0.02 milligrams per
milliliter,

The strips were then washed three times with

the physiologic saline/antibiotic solution.
Once washed, the strips were then cut into two centi
meter square pieces and placed one square in each sterile
Falcon culture dish (Bioquest, Inc,, Rockville, Maryland),
Under these asceptic conditions, in which all instruments
are kept sterile and all working surfaces are constantly
wiped down with seventy percent methanol, a large number of
dishes can be obtained from each strip.

To each dish, 3*0

milliliters of sterile nutrient media containing Eagle’s
complete MEM (L-glutamine, vitamins, non-essential amino
acids added)(Bioquest, Inc., Rockville, Maryland), twenty
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percent fetal calf serum (Bioquest), and the sterile anti
biotic solution quoted earlier in the text were added.
Culture dishes were placed twenty to a sterile dessicator, which contained approximately thirty milliliters of
sterile distilled water to keep the dessicator humid.
After some initial problems due to growth of mold in the
water at the bottom of the dessicator, some Nystatin (0.02
milligrams per milliliter) was used.

This concentration

brought the mold problem under control for the period of
time the tissues were being cultured.
Prior to sealing the dessicators, each one was
charged with a five percent carbon dioxide-balance air mix
ture.

They were then sealed and placed in an Amisco in

cubator set for 37»5°C.
Media was changed every other day for the first ten
days, and twice a week after that for as long as the tissues
were used or until they became necrotic or contaminated,
The atmosphere was changed every day in every dessi
cator or whenever they were opened (Kasten, 1973)■
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Preparation of the Xanthine Oxidase Solution
Milk xanthine oxidase (ICN Nutritional Biochemicals,
Cleveland, Ohio) was diluted one time with a sterile
sodium phosphate buffer (pH 7,0) solution and the concen
tration needed for the experiment determined by a publi
shed fluorometric method (Haining, Legan, 1967).
An Amino-Bowmen Spectrophotofluorometer was used in
determining the concentrations required,

The emission

wavelength was set at 352 nanometers and the excitation
wavelength was set at 315 nanometers. The fluorometric
assay consisted of reacting 2.7 milliliters of a phosphate
buffered substrate for the enzyme with 0,3 milliliters of
the phosphate buffered enzyme, incubated for thirty min
utes at 30°C,

Readings on an aliquot were taken every five

minutes from the start of the reaction to the finish,

The

buffered substrate used was 2-amino-4-hydroxypteridine
(Sigma Biochemicals, St. Louis, Missouri),

A stock solu

tion of the substrate was made by dissolving 8,15 milli
grams of the substrate with a few drops of 0.2N sodium
hydroxide, then diluting to 100 milliliters with distilled
water, in a volumetric flask.

The stock solution, 0,0005M

2=aminc-^—hydroxypteridine, was kept frozen between uses.
Enzyme concentration was determined by the amount of
fluoresence given off by the substrate which is oxidized
in the reaction,

The fluoresence given off is directly
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proportional to the enzyme concentration.
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The Addition of Isotopic Lipoprotein and 1?B Estradiol
to the Cultures
Under aseptic conditions, media was removed by care
ful aspiration through a sterile Pasteur pipette and re
placed with 3.0 milliliters of a sterile phosphate buffered
saline solution.

The tissue was washed once with this

solution and replaced by 2.0 milliliters of fresh sterile
medium containing five percent lipoprotein-deficient
serum.

Lipoprotein-deficient serum was made by extracting

the low density lipoprotein from the fetal calf serum used
in the culture media (Burnstein, Scholnick, 1972).
After twenty-four hours of growth in the medium con
taining lipoprotein-deficient serum, the medium was removed
by aspiration with a sterile Pasteur pipette and replaced
with 2.0 milliliters of medium containing 0,6 milliliters
of iodine 125 low density lipoprotein solution.

The cul

tures were then placed on a rotary shaker set for fifty
oscillations per minute, for one minute at 37.5°C.

This

was to insure an even distribution of isotopic lipoprotein.
The dishes were then placed back into their respect
ive dessicators, charged with five percent carbon dioxidebalance air and incubated for six hours.

The above method

was used on dishes that would serve as controls.
To dishes that would serve as the experiment, the
above procedure was repeated with the exception that the
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xanthine oxidase solution was added to the dishes also.

A

third set of dishes received the isotopic lipoprotein, the
xanthine oxidase and three hours afterwards, 17B estradiol
solution.
After six hours, the medium containing the iodine 125
low density lipoprotein was aspirated off with a sterile
Pasteur pipette.

Each tissue was washed three times in

rapid succession with 3*0 milliliters of cold buffer con
taining 50mM Tris (pH 7.5)• 0.15M NaGl, and sterile dis
tilled water.

After the washes, 1.0 milliliters of buffer

prewarmed to 37.5°c was added to the tissues and incubated
for two minutes.

The tissues were then washed with 3*0

milliliters of buffer.
The tissues were ground up in Kimax 2.0 milliliter
tissue homogenizers, one square piece to a homogenizer.
Before homogenization, 2.0 milliliters of buffer were added
to each homogenizer.

After a homogenized solution was ob

tained, 1.0 milliliters of Triton X (Beckman) was added
to the solution to aid in solubilizing the samples.

The

samples were then placed in a 50°C oven for one hour to
further insure that all the tissues had been digested.
After one hour, all samples were added to 10.0 milliliters
of scintillation cocktail (P0P0P-P0P in xylene) in 20.0
milliliter Kimble borosilicate liquid scintillation coun
ter vials.

The vials were then counted in a Packard Tri-

Carb 3310 Refrigerated Liquid Scintillation Counter for
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one minute (Brown, Golstein, 197^*; Brown, Goldstein, 1975)*
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RESULTS

Table I and II show the counts per minute per gram
of aortic tissue.

In comparing the addition of xanthine

oxidase to the metabolism of iodine 125 lipoprotein versus
the controls of just uptake of iodine 125 lipoprotein,
there was approximately an 80 percent increase in the
uptake of the low density lipoprotein.

This difference,

when tested by the Student*s t test for significance was
shown to be statistically significant at the probability
level of p<0.001 (Table II).

The data, therefore, upholds

the hypothesis that xanthine oxidase plays a key role in
the formation of atherosclerosis, as seen by an increase
in the cholesterol intake by an increased tissue uptake
of low density lipoprotein.
A change in membrane permeability is observed when
treated with iodine 125 low density lipoprotein and xan
thine oxidase with counts

k,99

times greater in tissues

treated with xanthine oxidase than those not treated, as
seen in Figure 1, which is a bar graph of Tables I and II.
Data from Table I and II concerning the latter part
of the research, show that the counts per minute per
gram of aortic tissue which were treated with iodine 125
low density lipoprotein, xanthine oxidase, and 17B estra
diol were lower than those treated with iodine 125 low
density lipoprotein and xanthine oxidase only.

The

2b
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difference between the tissue which had xanthine oxidase
alone and that with 17B estradiol was, according to Table
II and Figure 1, a decrease of 13 percent in the counts per
minute of the latter,

This decrease was proven to be sta

tistically significant by the Student's t test.
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Table I

Results of the Addition of Isotopic Low Density Lipopro
tein, Xanthine Oxidase, and 17B Estradiol to Cultured
Aortic Tissue

Sample run
Number

Sample
Description

1.

I125
Lipoprotein

Number of
Tissues per
Sample

Mean C.P.M.*
per gm.
+ S.D,**

6

11250 +2138

2.

6

11250 +2162

3*

6

10800 +2383

A.

6

11516 +2577

r'

6

10866 +1866

6

11830 +1861

6

10900 +2191

6

A9330 +9776

6

52660 +6508

6

58500 +5 A30

6

65660 +6 3 5 ^

6

51330 ^5760

?•

7.

1.
2.
3.

5>

I ^
Lipoprotein
and Xanthine
Oxidase

6.

6

61330 +8950

7.

6

52500 +13095

-Mean counts per minute per gram of aortic tissue
+ Standard Deviation
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Table I (corvt.)

Results of the Addition of Isotopic low Density Lipopro
tein, Xanthine Oxidase, and 17B Estradiol to Cultured
Aortic Tissue

Number of
Tissues per
Sample

Mean C.P.M.
per gm.
+ S.D.

12

48000 +9438

12

52916 +8005

12

48975 +9488

4.

12

46660 +7585

5.

12

46360 +3640

6.

12

49330 +7088

Sample run
number

Sample
Description

1.

X125
Lipoprotein,
Xanthine
Oxidase, and
17B Estradiol

2.
3-
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Table II

Results of the Addition of Isotopic low Density Lipopro
tein, Xanthine Oxidase, and 1?B Estradiol to Cultured
Aortic Tissue Analyzed Statistically According to the
Student’s t Test

Sample
Description

Pooled Data
Sample
Number with
C.P.M. per
gm, + S.D.

x125

11200+3600
N=42 samples

Lipoprotein
1125
Lipoprotein
and Xanthine
Oxidase

Tstatistic
number
Degrees ofFreedom

Probability
Value of
Non-Significance between Samples

51.2
82,0

p < 0,001

Sj3 .
110.0

p< 0,001

55900+56hO
N=ij-2 samples

j-125

^8650+2230
Lipoprotein,
N=70 samples
Xanthine
Oxidase and
17B Estradiol
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Figure 1
A Bar Graph of the Results from the Statistical Analysis
of Table I and of Table II

C.P.M./gm.

X125

Lipoprotein
9.0 x 10

■125

Lipoprotein
and Xanthine
Oxidase

-125

Lipoprotein,
Xanthine
Oxidase and
17B Estradiol

8.0 x 10

7.0 x 10

6.0 x 10^

5.o x 10

4.0 x 10

4

3.0 x lo

2.0 x 10

1.0 x 104

0.0 X 10
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D IS C U S S IO N

OF

F IN D I N G S

The physical progression of atherosclerosis may occur
as follows,

Discrete cellular parts of normal intima gain

excess cholesterol, which separates into a second, cholesterol
ester phase within the cells to form fatty streaks.

Some of

those lesions "become supersaturated with free cholesterol
and form intermediate lesions,

This effect leads, in

some lesions, to precipitation of a third, cholesterol
crystal phase and to cell death, necrosis and formation of
the largely acellular gruel plaque (Small, 1977)•
Low density lipoprotein "binds to a cell surface
receptor (Brown, Goldstein, 1976) and is then taken into
the cell in an endocytotic vesicle.

This vesicle fuses

with the primary lysosome to Term a secondary lysosome
in which the various constituents of the low density lipo
protein are broken down.

The protein is metabolized to

peptides and amino acids (Brown, Goldstein, 1976); the
phospholipids and triglycerides are hydrolyzed to fatty
acids and small water-soluble molecules and the cholesterol
esters are hydrolyzed by a hydrolase with a pH of four
point five to free cholesterol and fatty acid (Brown,
Goldstein, 1976).

The free cholesterol must then tra

verse the lysosomal membrane to enter other parts of the
cell, in which it turns off the synthesis of new cholesterol,
probably inhibits that of new low density lipoprotein

30
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receptors and. perhaps impedes hydrolysis of stored cho
lesterol ester (Brown, Goldstein, 1976).

If excess free

cholesterol is taken into the cell, it is re-esterified,
predominantly with oleic acid in the Golgi system by acyl
coenzyme As cholesterol acyl transferase (AGAT),

If the

cholesterol ester solubility in the membrane system is
exceeded, the excess will form separate cholesteryl-oleate
rich droplets.

These droplets represent a pool of stored

cholesterol; in the absence of other sources of cholesterol,
they may be hydrolyzed by a cytoplasmic cholesterol-ester
hydrolase,
Since most cells do not secrete cholesterol esters
(except for hepatocytes and intestinal epithelial cells),
free cholesterol must make its way to the outer half of
the plasma cell membrane where it may be removed by the
appropriate acceptors of high density lipoprotein.

Cho

lesterol enters the intact high density lipoprotein and the
lecithin-cholesterol acyltransferase reaction converts it
to a cholesterol ester, where it is removed,

This cel

lular uptake, metabolism and removal of cholesterol is
considered to be a normal sequence in the cell.
Since the cellular uptake, metabolism and removal of
cholesterol has been detailed above, exactly how does
the cholesterol balance become unbalanced to the pos
itive column?

Many mechanism have been proposed (Small,

1977), one of which has some relation with the work I

R eproduced with permission of the copyright owner. Further reproduction prohibited without permission.

32

have done here.

That is the uptake of a chemically mod

ified low density lipoprotein.

If abnormal cholesterol-

containing particles such as chemically modified, pos
itively charged low density lipoprotein come in contact
with the negatively charged plasma cell membrane, the
cholesterol sticks to the membrane and is internalized in
the cell.

Recently, cholesterol esters with a com

position similiar to that of low density lipoprotein have
been shown to accumulate in fibroblasts incubated with
positively charged low density lipoprotein (Basu, Ander
son, Goldstein, 1977).
It is possible that the low density lipoprotein may
then be one of the targets of xanthine oxidase.

The enzyme

combines with a portion of the apoprotein which may have
a configuration similiar to the enzyme’s normal substrate.
After the reaction, the apoprotein portion would be changed
which could possibly alter the configuration of the mole
cule enough so the molecule would now have a positive
charge and enter the cell by phagocytosis.

This route of

entry would be different from the one normal mode of entry
by the receptor and would mean additional amounts of cho
lesterol would be entering the cell, at a rate faster then
the cell can get rid of it.
In addition to a possible modification of the low
density lipoprotein, it is possible the enzyme xanthine
oxidase may have a more direct effect on the cell itself.
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One of the current explanations for the development of
atherosclerosis is the stimulation of cells by a mutagen
to migrate.

Normal arteries are composed of three mor

phologically distinct layers.

The intima, or inner layer

of the artery, consists in the newborn and in children,
of a narrow region bound on one side by a single layer of
endothelial cells that line the lumen of the vessel and
on the other side by the internal elastic lamina, a per
forated sheet of elastic tissue.

Between these two

boundaries, are occasional smooth muscle cells surrounded
by various extracellular components of connective tissue
matrix.

With increasing age, smooth muscle cells and

extracellular matrix components accumulate slowly within
the intima, increasing its thickness.

The media, or middle

layer of the artery, consists of large numbers of smooth
muscle cells, each surrounded by a small amount of collagen,
elastic fibers, and other connective tissue matrix components,
The morphology of the media, in contrast to that of the in
tima generally does not alter with age.

With atherosclerosis,

some event stimulates cells to migrate into localized
region of the intima and to proliferate.

Cholesterol

homeostasis is absent or impaired in these cells; their
cholesterol balance becomes positive and a patch of
cholesteryl-oleate rich foam cells comprising the first
stage of the disease, a fatty streak, is formed.

The

stimulus which causes this proliferation could well be
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the enzyme xanthine oxidase.

The enzyme may combine with

the low density lipoprotein receptor, changing the con
formational structure so the cell membrane permeability
to the low density lipoprotein molecule changes,

There

fore, the cell would have a greater amount of cholesterol
to deal with because of an increased low density lipo
protein influx.

Experiments have shown that low density

lipoproteins have a greater growth promoting effect than
high density lipoproteins, even when the lipoprotein
cholesterol concentrations are equal (Holly, Kiernan, 1971,
Ross, Glomset, 1973)*

role played by the protein com

ponents is unclear, but it seems likely that lipoproteins
provide lipids that can be used in the cell membrane
formation process.

This may suggest that certain cells can

use lipoprotein cholesterol to form membranes and that
the rate of biosynthesis of membrane cholesterol may limit
cell proliferation in the absence of an external lipo
protein source.

If the cell is exposed to an increased

low density lipoprotein concentration because of an in
creased permeability of the cell membrane by xanthine
oxidase, this increased concentration could well play
a role in the mutational aspects of smooth muscle in
filtration,
Figure 1 tends to support this idea with cultures
exposed to iodine 125 low density lipoprotein and xanthine
oxidase having counts per minute 4,99 times greater than
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those not treated with xanthine oxidase.
Besides the conformational change causing an increased
uptake of the low density lipoprotein, a second change is
seen in the interruption of the negative feedback sys
tem on the cholesterol synthesis (Brown, Goldstein, 19?^)•
Cholesterol synthesis is carefully regulated by the low
density lipoprotein receptor.

When the receptor has little

or no low density lipoprotein molecules bound, the cell sets
up a pathway for the synthesis of the needed cholesterol,
due to the fact that little or no cholesterol is being sup
plied externally.

If the receptor is altered, this feed

back mechanism is destroyed, and the cell is therefore
exposed to a double-barrel effect.

This effect can also

happen if the cell is receiving an altered lipoprotein
molecule due to the combination with xanthine oxidase,

The

accumulation of positive carged lipoprotein by phagocytosis
would be "blind" to the cell, because the structurally alter
ed lipoprotein would not inhibit the negative feedback
system.

Therefore, a double-barreled effect of first an

increasing intracellular concentration of cholesterol by
either of the two methods mentioned above, and second, the
cell itself is still synthesizing cholesterol because it
has lost any inhibitory control that the receptor would
give.
Evidence does exist that at least a partial "healing"
of atherosclerotic lesions occurs (Ross, Glomset. 1973)«
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In balloon catheterization studies performed on adult
macaques, which give lesions similar to those seen in
atherosclerosis, the intimal lesion contained as many as
fifteen layers of smooth muscle cells with associated con
nective tissue matrix,

Three months after the injury, the

intimal lesion was much thinner and contained only one or
two layers after six months in animals that had normal
cholesterol levels.

If "healing" occurs after experi

mental injury to the intima of nonhuman primates, why are
humans so susceptible?

One possibility is that in man's

case, the injury is recurrent.

With the xanthine oxidase

hypothesis, the enzyme is located in the fat globule in
regular homogenized, pasteurized, dairy milk of a bovine
source, found on refrigerated shelves in grocery stores
across the world.

With this in mind, one can see how

easily it is to have the repetitive damage done to the
intima.

However, there is one exception to this thinking;

that is, it has been shown that pre-menopausal females
have a lower incidence of atherosclerosis than do their
male counterparts, and that the rate of the incidence of
the disease jumps to reach a comparable rate seen in males,
in postmenopausal females (Roussos, 1963).

What is it in

these premenopausal women that offers some protection to
them against atherosclerosis?

The major difference be

tween premenopausal and postmenopausal women is a change
in the hormonal balance, especially that of the estrogen
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output.

After menopause, estrogen concentration drops and

is usually supplied by external means.
17B estradiol is the major hormone.

Of the estrogens,

It is possible that

17B estradiol could very well have an inhibitory effect on
xanthine oxidase.

The hormone could react with the enzyme

directly, tieing up the enzyme so it may not react with
the low density lipoprotein or the low density lipoprotein
receptor.

The hormone's position on the receptor could pre

vent subsequent alteration by the xanthine oxidase due to
steric interference of the 17® estradiol molecule.

This

interference would prevent proper enzyme substrate binding
needed for a complete reaction.

Due to the presence of

estradiol's four carbon rings, the xanthine oxidase would
not be able to attach its active site properly and there
fore not react.
Counts per minute per gram of aortic tissue which were
treated with iodine^2^ low density lipoprotein, xanthine
oxidase, and 1?B estradiol were lower than those treated
with iodine^2^ low density lipoprotein and xanthine oxi
dase only.

The differance between the tissue which had

xanthine oxidase alone and that with 1?B estradiol was a
decrease of thirteen percent in the counts per minute of
the latter.
In addition to this, it is interesting that one of the
most effective drugs on the market today for fighting
atherosclerosis, Clofibrate, has a structure similar to
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that of the estrogen 1?B estradiol.

Clofibrate group of

anti-atherosclerosis drugs may act by displacement of
coenzymes or hormones on anionic binding sites on plasma
proteins (Cutting, 1972).<
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CONCLUSIONS
The hypothesis concerning the role of xanthine
oxidase in causing an increased intake of low density
lipoprotein which contributes to the formation of the
atherosclerotic plaque, and the enzyme's inhibition by
the female hormone 17B estradiol have been proven by the
data and discussion presented in this thesis.

Of course,

further work is needed into this complex problem concern
ing this disease process.

Further study is needed in

the reaction kinetics between xanthine oxidase and both
the low density lipoprotein molecule and the low density
lipoprotein receptor.

In addition, further insight is

required into exactly how the

l?B

estradiol molecule

carries out its inhibitory action against the enzyme,
xanthine oxidase.
With this knowledge, it is possible to foresee that
in the near future the first clear insight into the
atherosclerotic disease process will become known, and
the possibility of formulating a preventative therapy
against this pathology will arise.
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